Characterization of Ras Y4H mutants in Drosophila

Prashath Karunaraj1,2,3, Chalita Washington1, Max Luf1,2

  • 1Oncological Sciences, Icahn School of Medicine at Mount Sinai.

PubMed

Insights

Ras signaling is crucial for development and cancer. Mutations in Ras Tyrosine 4 (Y4) in fruit flies and humans disrupt inhibitory ubiquitination, potentially driving cancer progression.

Area of Science:

  • Molecular biology
  • Developmental biology
  • Oncology

Background:

  • Ras signaling is essential for cellular functions and development across species.
  • Dysregulation of Ras signaling is implicated in various cancers, including glioblastomas.
  • Specific mutations in human HRas, particularly at Tyrosine 4 (Y4), are linked to cerebellar glioblastomas (cGBMs).

Purpose of the Study:

  • To investigate the functional consequences of Y4 mutations in Ras signaling.
  • To determine if Y4 mutations affect Ras ubiquitination by Rabex-5.
  • To assess the relevance of these findings to human glioblastoma pathogenesis.

Main Methods:

  • Utilized *Drosophila* as a model organism to study Ras signaling.
  • Introduced analogous Y4H mutations into *Drosophila* Ras.
  • Assessed Ras ubiquitination levels in cells.
  • Analyzed wing vein phenotypes in *Drosophila* to evaluate Ras gain-of-function.

Main Results:

  • Y4H mutations in *Drosophila* Ras reduced sensitivity to Rabex-5-mediated ubiquitination.
  • Mutant Ras exhibited an increased frequency of vein phenotypes per wing compared to wild-type Ras.
  • These findings suggest a Ras gain-of-function mechanism.

Conclusions:

  • Ras Y4 is critical for inhibitory ubiquitination by Rabex-5.
  • Y4H mutations confer Ras gain-of-function, consistent with their presence in human cGBMs.
  • This study provides a model for understanding the role of Ras Y4 mutations in glioblastoma development.